CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy

Por Xiangyu Chen, Cheng Chen, Jun Huang, Wei Yao, Yanyan Zhang, Pengcheng Wang, Qing Wu, Lisha Wang, Yuan Luo, Zhiming Wang, Minglu Xiao, Luoyingzi Xie, Guoshuai Cao, Shun Lei, Zhengping Wei, Jingyi Fang, Xingxing Yang, Qizhao Huang, Lifan Xu, Junyi Guo, Shuqiong Wen, Jianfang Tang, Jianqiang Ye, Ran He, Lilin Ye
Publicado em 2022-05-01